Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property

Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are available in respect of a submission that results in an NOC. 2021-07-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicCOVID-19 drugamendementFood and Drug Regulationsdrugsmanufacturerssubmissionnotice of complianceintellectual property protections Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual propertyHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/food-drug-regulations-amendments-covid-19/intellectual-property.html Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual propertyHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/reglement-aliments-drogues-modifications-covid-19/propriete-intellectuelle.html

As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are available in respect of a submission that results in an NOC.

Data and Resources

Similar records